97 results
Page 4 of 5
8-K
EX-99.1
koisaj7ldid4a1v
16 Oct 15
Regulation FD Disclosure
12:00am
8-K
EX-99.2
ot9ow14c0re o7owu
16 Oct 15
Regulation FD Disclosure
12:00am
424B5
sg13o9sardiamozjt
11 Dec 14
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
57kx0s
11 Dec 14
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12:00am
424B5
1kuk61pbp xxf
9 Dec 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
zlrga3s6jo4f49ql4hd
8 Dec 14
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
12:00am
8-K
EX-99.1
63r9bj d62by1wzi5v
19 Nov 14
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120
12:00am
8-K
EX-99.1
77j1pjjvfgn w5xvtaa
15 Oct 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
dh77i1k
7 Aug 14
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
c02aroi1
16 Jun 14
Other Events
12:00am